ASPERFLEX- menthol and methyl salicylate cream 
Akron Pharma Inc.

----------

AsperFlex
Tough on Pain
Non-greasy-Topical Analgesic Cream
Deep Penetrating Pain Relief

DRUG FACTS

Active Ingredient

Menthol 10%

Methyl Salicylate 15 %

Purpose

External analgesic

Uses

temporary relieves the minor aches and pain of muscles and joints associated with:

Warnings

For external use only

Do not use

  • on wounds or damaged skin
  • with a heating pad
  • on a child under 12 years of age with arthritis-like conditions

Ask a doctor before use if you have

redness over the affected area

When using this product

  • avoid contact with eyes or mucous membranes
  • do not bandage tightly

Stop use and ask a doctor if

condition worsens or symptoms persist for more than 7 days

■ symptoms clear up and occur again within a few days

■ excessive skin irritation occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

adults and children 12 years of age and older:

apply to affected area not more than 3 to 4 times daily

children under 12 years of age: consult a doctor

Other Information

store at 20°-25°C (68°-77°F).

Close cap tightly after use.

Inactive ingredients

citric acid, glyceryl monostearate, lanolin, methylparaben, propylene glycol, propylparaben, purified water, stearic acid, trolamine

Questions or Comments?

Call toll-free 1-877-255-6999.

cream label

ASPERFLEX 
menthol and methyl salicylate cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71399-6854
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL100 mg  in 1 g
METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE150 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
CITRIC ACID ACETATE (UNII: DSO12WL7AU)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
LANOLIN (UNII: 7EV65EAW6H)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TROLAMINE (UNII: 9O3K93S3TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71399-6854-385 g in 1 TUBE; Type 0: Not a Combination Product06/03/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01706/03/2024
Labeler - Akron Pharma Inc. (067878881)

Revised: 2/2023
Document Id: 6c387eb2-b208-4b18-a2db-f00dbda03cf5
Set id: 117de175-976d-44f3-85ed-3d127fbe3a7c
Version: 1
Effective Time: 20230212
 
Akron Pharma Inc.